Oncology

Gilead Sciences Women HIV Movement campaign
Favicon Fierce Biotech

JPM26: Gilead eyes new deals from a 'position of strength'

Across virology, oncology and inflammation, Gilead has "the luxury of being selective" in the external assets it considers adding to its pipeline.
Darren Incorvaia Jan 14, 2026 3:30am
Florida Florida flag FL FL flag

Novartis charts next US investment with new radiopharma plant

Jan 9, 2026 10:30am
Moderna

Moderna outlines 3-year business strategy in bid to break even

Nov 20, 2025 2:54pm
Regeneron

Regeneron to invest $2B in new Saratoga Springs production plant

Nov 18, 2025 10:15am
photo of a green light on a stoplight

Kyowa Kirin, Kura snag FDA nod for oral AML drug Komzifti

Nov 13, 2025 11:53am
Johnson Johnson

J&J eyes earlier myeloma treatment with ph. 3 Tecvayli combo win

Oct 16, 2025 8:10am
More News

AZ, Daiichi's Datroway scores overall survival win in TNBC

Oct 6, 2025 10:48am

Jazz, Roche's small cell lung cancer combo snags FDA approval

Oct 3, 2025 10:00am

AbbVie unveils $70M expansion in MA

Oct 1, 2025 9:05am

AZ, Daiichi's Enhertu notches another win in early breast cancer

Sep 29, 2025 12:00pm